ArticleThe Lancet regional health. Western Pacific2025

Pembrolizumab monotherapy for previously treated metastatic HER2-negative breast cancer with germline

Gwo Fuang Ho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.